OBAMA 2008:”I’LL FIX EVERYTHING-IT’S EASY” OBAMA 2011″IT’S SO BAD I NEED MORE TIME”-WHICH IS the BIGGER LIE?
Question by AntiPc-inHD: OBAMA 2008:”I’LL FIX EVERYTHING-IT’S EASY” OBAMA 2011″IT’S SO BAD I NEED MORE TIME”-WHICH IS THE BIGGER LIE?
In order to get elected in 2008 the President campaigned on how intelligent he was-and due to that he could fix everything…..fix the economy-fix secret back door meetings-fix too many lobbyists-fix Iran issues. So enough people bought the goods he was selling to get him elected. NOW that appears his presidency failed-he and his minions have changed their tune to: “We didn’t know it was this bad-so give us four more years.” If he was so smart as he promised to get elected-why DIDN’T he know it was “this bad.”? Isn’t the truth that the honest 2011 campaign should say “We didn’t know that we don’t know what we’re doing?”
Best answer:
Answer by Jimmy Whispers MMXII
Yes, i agree his statement of 2008 was unrealistic and so is much of his views, but try listening to his competitors speak, they’re the most unrealistic bunch I’ve ever seen.
Know better? Leave your own answer in the comments!
TEXT-S&P summary: Sanofi
Filed under: drug treatment news 2011
The ratings are also supported by our view of the group's exposure to highly diversified and sizable treatment areas, underpinned by a product portfolio including five blockbuster drugs (with sales of more than $ 1 billion in 2011). The ratings are …
Read more on Reuters
Newly Minted Bargains—For Sale: Busted IPOs
Filed under: drug treatment news 2011
Groupon (ticker: GRPN), for instance, is about as busted as it gets, down 80% from its November 2011 IPO price of $ 20. The stock … An FDA advisory panel reviews a Janssen Products division's treatment for drug-resistant tuberculosis. NYSE Euronext …
Read more on Barron’s
Novartis drug Exjade(R) recommended by CHMP for EU approval to treat …
Filed under: drug treatment news 2011
Novartis International AG / Novartis drug Exjade® recommended by CHMP for EU approval to treat patients with non-transfusion-dependent thalassemia syndromes . Processed and transmitted by Thomson Reuters ONE. …. In 2011, the Group's continuing …
Read more on Reuters